2-Isopropyl-4-methyl-1,3-dioxolane
Common Name: |
2-Isopropyl-4-methyl-1,3-dioxolane |
IUPAC Name: |
4-methyl-2-propan-2-yl-1,3-dioxolane |
Molecular Formula: |
C7H14O2 |
SMILES: |
CC1COC(O1)C(C)C |
Inchi: |
1S/C7H14O2/c1-5(2)7-8-4-6(3)9-7/h5-7H,4H2,1-3H3 |
Inchi Key: |
NWXXKKDLGZLEGH-UHFFFAOYSA-N |
Cas No: |
67879-60-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
130.18 |
Mass (g/mol) |
130.099 |
Molar Refractivity |
35.82 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
1 |
Rings |
1 |
TPSA |
18.46 |
Hetero Atoms |
2 |
Heavy Atoms |
9 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
142.00 to 143.00 |
Vapor Pressure (mmHg@25.00 °C) |
6.758 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
1.404 |
iLOGP |
2.38 |
XLOGP3 |
1.63 |
WLOGP |
1.40 |
MLOGP |
0.97 |
ESOL Log S |
-1.61 |
ESOL Solubility (mg/ml) |
3.21 |
ESOL Solubility (mol/l) |
0.025 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.63 |
Ali Solubility (mg/ml) |
3.05 |
Ali Solubility (mol/l) |
0.02 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-0.90 |
Silicos-IT Solubility (mg/ml) |
16.3 |
Silicos-IT Solubility (mol/l) |
0.13 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.94 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.449 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
1 |
Acute Oral Toxicity |
3.144 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |